DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $436,577 | +1.3% | 1,760 | -2.0% | 0.28% | -3.1% |
Q2 2023 | $430,946 | +72327.9% | 1,796 | -24.0% | 0.29% | -47.7% |
Q1 2023 | $595 | -26.3% | 2,363 | -22.2% | 0.56% | -26.7% |
Q4 2022 | $807 | -99.9% | 3,039 | -21.7% | 0.76% | -13.2% |
Q3 2022 | $1,003,000 | -8.3% | 3,881 | -10.0% | 0.88% | -3.8% |
Q2 2022 | $1,094,000 | -15.3% | 4,314 | -2.0% | 0.91% | +1.9% |
Q1 2022 | $1,291,000 | -52.8% | 4,402 | -49.0% | 0.90% | -10.9% |
Q4 2021 | $2,736,000 | +110.3% | 8,634 | +102.1% | 1.00% | -4.2% |
Q3 2021 | $1,301,000 | +13.2% | 4,272 | -0.2% | 1.05% | +13.4% |
Q2 2021 | $1,149,000 | +26.3% | 4,282 | +6.0% | 0.92% | +9.7% |
Q1 2021 | $910,000 | +5.1% | 4,041 | +3.7% | 0.84% | -7.6% |
Q4 2020 | $866,000 | +18.3% | 3,898 | -5.8% | 0.91% | -17.6% |
Q3 2020 | $732,000 | 0.0% | 4,138 | 0.0% | 1.10% | 0.0% |
Q2 2020 | $732,000 | +21.8% | 4,138 | -4.7% | 1.10% | -14.4% |
Q1 2020 | $601,000 | +1.5% | 4,342 | +12.6% | 1.29% | +17.7% |
Q4 2019 | $592,000 | +19.6% | 3,855 | +12.4% | 1.10% | +8.2% |
Q3 2019 | $495,000 | +9.5% | 3,430 | +8.4% | 1.01% | +4.8% |
Q2 2019 | $452,000 | -32.5% | 3,165 | -37.7% | 0.97% | -17.4% |
Q1 2019 | $670,000 | +43.2% | 5,077 | +11.8% | 1.17% | +19.0% |
Q4 2018 | $468,000 | +49.0% | 4,542 | +57.1% | 0.98% | +63.3% |
Q3 2018 | $314,000 | +13.4% | 2,892 | +3.2% | 0.60% | +12.5% |
Q2 2018 | $277,000 | +8.6% | 2,802 | +7.7% | 0.54% | -2.0% |
Q1 2018 | $255,000 | – | 2,602 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |